Hormone Replacement Therapy Raises Risk of Lung Cancer Death

The hormone replacement therapy taken by millions of women to relieve hot flashes and other symptoms of menopause may raise the risk of dying from lung cancer. New findings from the landmark Women’s Health Initiative study show that women with non-small cell lung cancer are 59% more likely to die from the disease if they take combined estrogen and progestin.

Lack of Sleep Lowers Resistance To Illness."

In a resent study, “Sleep Habits and Susceptibility to the Common Cold.” Dr Sheldon Cohen, of the Department of Psychology at Carnegie Mellon University in Pittsburgh, Pennsylvania, and his colleagues found that poor sleep to be a predictor of low immunity. Researchers paid healthy male and female volunteers  $800 to have cold viruses sprayed up Continue Reading …

Social Networking Sites Have Myriad Trial-Related Uses

The information in this post was gathered from an article published by Deb Bortifz in eCliniqua, Innovative Management in Clinical Trials. eCliniqua offers PodCasts, WebCasts, White Papers and much more. Their ‘data-rich’ site is one of my primary research resources for an objective review of clinical trial process and results. March 2, 2009 | A Continue Reading …

Twice as many women die from stroke every year than from breast cancer

Overall, stroke is this country’s third-leading killer. About 700,000 Americans will have one this year, according to the American Stroke Association. But 55-percent of all strokes and 60-percent of stroke deaths occur in women. About 100,000 women die annually of stroke, 40,000 more than the number of men who die from it. The fact that Continue Reading …